Cargando…
Metabotropic Glutamate Receptors: Potential Drug Targets for Psychiatric Disorders
Metabotropic glutamate receptors (mGlu receptors) have emerged as new therapeutic targets for psychiatric disorders, such as schizophrenia, depression and anxiety with their regulatory roles in glutamatergic transmissions. To date, several ligands selective for each mGlu receptor have been synthesiz...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Open
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002053/ https://www.ncbi.nlm.nih.gov/pubmed/21160908 http://dx.doi.org/10.2174/1874104501004020020 |